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In 2009, Elizabeth H. Blackburn, Carol W. Greider and Jack W.
Szostak were jointly awarded the 100th Nobel Prize in Medicine or
Physiology for their discovery of ‘how chromosomes are pro-
tected by telomeres and the enzyme telomerase’ [1]. This prize
appropriately recognized the substantial merits of the vast array of
research and discoveries produced by these investigators and
their predecessors (including several Nobel Laureates) who set
out to understand the function of telomeres, their maintenance
and their role in cellular and organismal processes. Indeed, the
recent findings by Ronald DePinho and colleagues on the effects
of reversing the degenerative signs of aging in mice by reactivat-
ing telomerase further highlight the impact of telomeres and
telomerase in health and medicine [2].
The chronicles of telomeres and telomerase began with inves-
tigations into how cellular lifespan is controlled. In the early
1900s, Alexis Carrel (awarded the Nobel Prize in 1912) observed
the continuous growth of mammalian cells in culture and
 suggested that aging is ‘an attribute of the multicellular body as a
whole’ [3]. In 1961, Hayflick and colleagues observed that normal
diploid cells have a finite replicative capacity (termed Hayflick
limit) and further showed in 1975 that the control centre for mito-
sis is located within the nucleus of the cell [reviewed in 4]. But the
nature of the replication clock remained a puzzle.
In the 1930s, Hermann Muller (Nobel Prize in 1946) and
Barbara McClintock (Nobel Prize in 1983) made the astute
 observations that the ends of chromosomes protected the chro-
mosomes from fusing together [3, 4]. Muller coined the term
‘telomeres’ (from the Greek telos for end and meros for part) to
described the ends of the chromosomes [1]. In 1972, James D.
Watson (Nobel Prize in 1962) poised the ‘end replication problem’
in which the 3 ends of linear duplex DNA cannot be  completely
replicated by DNA polymerase machinery. Around the same time,
Alexy Olovnikov made the connection between the end replication
problem and Hayflick’s limit. Olovnikov predicted that cells have a
special mechanism to permit maintenance of chromosome ends
which prevented the end replication problem (and  cellular aging)
[4]. Finally, the advent of modern molecular and cellular biology
techniques allowed the connection between Muller’s and
McClintock’s findings and Watson’s and Olovnikov’s ideas to be
understood at the molecular level. These new findings ultimately
defined the importance of telomeres in cellular lifespan, and
 perhaps also in whole organismal health.
In the late 1970s and 1980s, Elizabeth Blackburn mapped 
the repetitive DNA sequences at the ends of chromosomes 
(telomeres) of simple organisms [1, 3, 4]. The repetitiveness of
these sequences were later shown to be not only evolutionary
 conserved across multiple organisms, but that they were essential
for relevant for chromosome integrity. Blackburn collaborated with
Jack Szostak to show that these telomeric sequences from one
organism (Tetrahymena) protected linear DNA molecules from
degrading when introduced into cells of another organism (yeast).
We now understand that telomeres are protected by multiple
 associated proteins and in mammals this complex has been
termed shelterin [5]. Furthermore, the newly seeded telomeres in
yeast built on the Tetrahymena repeat templates were longer. This
led to the hypothesis that a telomere-synthesizing enzyme (i.e.
telomerase) existed.
Since the cloning of one component of telomerase (i.e. its RNA
template used for new repeat addition) in 1985 by Elizabeth
Blackburn and her then graduate student Carol Greider, the field of
telomere biology has vastly expanded [1, 3, 4]. Tom Cech (Nobel
Prize 1989) cloned the catalytic component of the enzyme telomerase
and others have shown that telomerase is a complex consisting of
many other proteins regulating it structure and function. With the
discovery of their sequences, telomere length and telomerase
expression or activity can now be measured and these measure-
ments can be used as tools for diagnostics and physiological
association studies. For example, there is now strong evidence of
the association of telomere shortening or dysfunction, replication
potential of cells, and increased risk of several age-related diseases
[2, 6, 7]. Moreover, the evidence for a link between telomeres and
 cellular lifespan was obtained when the catalytic component of
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2telomerase was introduced into normal human cells that ordinarily
lack  telomerase and these cells bypassed the Hayflick limit of cel-
lular aging [8]. Ever since McClintock’s ground-breaking
 discoveries in maize, further investigations into telomere function
in plants and other model organisms continue to aid in our basic
understanding of how telomeres function in cells [9].
For modern medicine another key discovery has been the find-
ing that telomeres are maintained in cancer cells which facilitates
their immortal status [reviewed in 1]. This has led to investiga-
tions into how telomerase is normally active only in germ cells and
stem-like cells yet repressed in most of our somatic cells. The
possibility that the telomere maintenance pathway could be a tar-
get in cancer has also been investigated by multiple laboratories.
The impact of these discoveries on modern medicine is
becoming better understood. Given the accumulating new evi-
dence on the role of telomeres in cellular biology and human
health, it is timely to conduct a review series on telomeres and
telomerase hosted by the Journal of Cellular and Molecular
Medicine. In this review series, several researchers assess the
current status and future perspectives of the field, ranging from
telomere replication, diagnostics, molecular genetics, genetic dis-
eases associated with dysfunctional telomerase and therapeutic
targeting of telomeres and telomerase for age-related diseases
such as cancer. Even though telomeres and telomerase have been
studied for decades, the field is continually producing novel break-
throughs that have significant potential to influence human health
and treatment. Therefore, we have not seen the end of the telom-
ere and how it can have an effect on biology and medicine.
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